Evaluation of isatuximab in patients with soft-tissue plasmacytomas: An analysis from ICARIA-MM and IKEMA-Reference-Cited by-同舟云学术

Evaluation of isatuximab in patients with soft-tissue plasmacytomas: An analysis from ICARIA-MM and IKEMA

Published:2022-11 Issue: Volume:122 Page:106948
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Beksac Meral,Spicka Ivan,Hajek Roman,Bringhen Sara,Jelínek Tomas,Martin Thomas,Mikala Gabor,Moreau Philippe,Symeonidis Argiris,Rawlings Andreea M.,van de Velde Helgi,Richardson Paul G.

Funder

Sanofi

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference37 articles.

1. Multiple myeloma: EHA-ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Dimopoulos;Hemasphere,2021

2. Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma - an IMWG research project;Usmani;Blood Cancer J.,2018

3. Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations;Rosinol;Br. J. Haematol.,2021

4. Extramedullary disease in multiple myeloma - controversies and future directions;Sevcikova;Blood Rev.,2019

5. Predictors of inferior clinical outcome in patients with standard-risk multiple myeloma;Badar;Eur. J. Haematol.,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unusual extramedullary presentation in newly diagnosed multiple myeloma: Synchronous infiltration of the maxillary sinus, thyroid, breast and bilateral ovaries;Asian Journal of Surgery;2024-09

2. Multiple myeloma relapse as extramedullary plasmacytoma of the penis;Annals of Hematology;2023-09-25

3. Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients – real world evidence analysis;Annals of Hematology;2023-04-24